Introduction
============

Evidence that garlic derivatives could be employed in the treatment of cancer and other human diseases has been now widely provided. In fact, they are effective in promoting cell cycle arrest and apoptosis in several cancer cells \[[@b1]\], in increasing vasodilatation and inhibiting platelet aggregation and cholesterol synthesis \[[@b2]\]. When garlic is minced or crushed, enzymatic activity of allinase converts its major constituent alliin into allyl sulphur components \[[@b3]\], which are thought to be responsible for its flavour and aroma, as well as for its potential health benefits. It has been demonstrated that organosulphur derivatives account for the majority of the garlic anti-proliferative effects \[[@b4]\]. Among garlic organosulphurs with the highest anti-proliferative capacity, the water-soluble S-allyl cysteine (SAC) and S-allylmercaptocysteine (SAMC), and the oil-soluble diallyl disulphide (DADS) and triallyl disulphide (DATS) are included. The anti-proliferative effects of garlic organosulphur compounds seem to be related to their capacity to cause oxidative damage by increasing the production of reactive oxygen species (ROS). We have previously demonstrated that DADS exerts cytotoxic activity on neuroblastoma cells \[[@b5], [@b6]\], whereas cells well equipped with antioxidants such as adenocarcinoma gastric cells (notably rich in glutathione peroxidase) or neuroblastoma cells overexpressing copper, zinc superoxide dismutase (SOD1) are resistant to DADS \[[@b5], [@b7]\]. Moreover, we evidenced that DADS commits cells to apoptosis through a mechanism involving a ROS-dependent activation of JNK/c-Jun signalling pathway.

Cytoskeleton is a dynamic component of the cell as it is involved in maintenance of cell shape, intracellular trafficking, cell division, cell migration and adhesion. Cytoskeleton represents one of the preferential targets of ROS due to the relative high abundance of oxydizable residues of its protein constituents. It has been demonstrated that oxidative stress causes both microfilaments and microtubules disruption owing to oxidative modifications of specific methionine and cysteine residues of actin and tubulin \[[@b8]--[@b11]\]. Exposure of cells to pro-oxidants agents such as menadione, diamide or *tert*-butyl hydroperoxide results in disruption of microfilament network associated with the preferential oxidation of the conserved Cys^374^ of actin \[[@b8], [@b12]--[@b14]\]. More recent evidence indicates that also carbonylation may play a role in loss of cytoskeletal function \[[@b9], [@b15]\]. Moreover, ROS causes a rise in calcium concentration promoting dissociation of actin microfilaments as consequence of calpain-mediated cleavage of actin-binding proteins \[[@b16]\].

Importantly, cytoskeleton and cytoskeleton-associated proteins has been found to have a fundamental role in the processes leading to either stress stimuli resistance or apoptosis. For example, the dramatic morphological changes typical of apoptotic cells are due to a complete reorganization of the cytoskeleton, ensuring the orchestrated breakdown of the cell into apoptotic bodies and the maintenance of intact plasma membrane \[[@b17], [@b18]\]. Degradation of cytoskeletal proteins such as actin or intermediate filaments due to calpains or caspases activity also plays a crucial role in apoptosis commitment \[[@b19]--[@b21]\]. Detachment of microtubules-associated Bim from cytoskeleton is essential for its pro-apoptotic activity into mitochondria \[[@b22]\]; the loss of interaction of NF-E2-related factor-2 (Nrf-2) with the actin-anchored protein Keap1 leads to its nuclear localization and transcription of several cytoprotective and antioxidant genes that enhance cell survival \[[@b23]\]; the tyrosin kinase c-Abl, which has been found to associate with filamentous actin and to have a role in cell motility, inhibits cell differentiation and promotes apoptosis in response to genotoxic stress \[[@b24]\]. Moreover, abnormal phosphorylation of the microtubules-associated protein Tau has been now established to have a causative role in the processes leading to neuronal apoptosis in a variety of neurodegenerative diseases called tauopathies \[[@b25]\].

The use of cytoskeleton-disrupting agents in chemotherapy has been proposed as a strategy to selectively kill tumour cells \[[@b26]\]. Among the most used drugs, there are those belonging to the taxol-like group and Vinka alkaloids, which successfully perturb microtubules dynamics of proliferating cells \[[@b27]\]. In contrast, compounds targeting microfilaments, such as cytochalasins, display high cytotoxicity and for this reason are not currently employed in cancer treatment \[[@b28]\]. Several pieces of evidence suggest that apoptosis elicited by garlic derivatives is preceded by accumulation of cells in G2/M phase \[[@b4]--[@b6], [@b29]\]. Cell cycle arrest has been linked to direct interaction of garlic derivatives with cytoskeletal components, primarily microtubules. In this context, SAMC, DADS and DATS have been demonstrated to directly oxidize tubulin sulphydryl groups on specific Cys residues inhibiting mitotic spindle \[[@b30]--[@b34]\]. Disrupting effects on microfilaments have not been reported yet, however, allicin treatment causes perturbation of cortical actin polymerization in primary human T cells resulting in inhibition of cell migration \[[@b35]\].

Tau is considered the main microtubules-associated protein responsible for microtubules assembly and stabilization in cells of neuronal origin \[[@b36]\]. Deregulation of its function through altered phosphorylation on Ser or Thr residues has been claimed as the principal cause of cytoskeleton disruption in a number of neurodegenerative disease named tauopathies \[[@b25]\]. Recently, the involvement of Tau in microfilaments stabilization through a cross-linking mechanism has been also identified \[[@b37]\]. Tau cleavage and/or change in its phosphorylation state are important early factors in the failure of the microtubule network that occurs during neuronal apoptosis \[[@b38], [@b39]\] or upon treatment with microtubules poisons commonly used in cancer therapy \[[@b40]--[@b42]\].

In this report, we aimed at characterizing the events upstream of cell cycle arrest and apoptosis triggered by DADS in neuroblastoma cells. Particularly, we found a superoxide-mediated disassembly of both microfilaments and microtubules concomitant to Tau dephosphorylation *via* PP1. Our results give efforts to the employ of DADS as a potent anti-neuroblastoma drug by virtue of its widespread cytoskeleton disrupting action on proliferating neuroblastoma cells.

Material and methods
====================

Material
--------

Diallyl disulphide, proteases inhibitor cocktail, NAC, GSH ester, mouse monoclonal anti-actin, anti-α- and anti-β-tubulin were from Sigma (St. Louis, MO, USA). Goat polyclonal anti-p-cdk5 and mouse monoclonal anti-Tau were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Mouse monoclonal anti-Tau-1 antibody (clone PC1C6) was from Millipore-Chemicon (Billerica, MA, USA). Rabbit polyclonal anti-p-Bcl-2 was from Cell Signalling Technology Inc. (Danvers, MA, USA). IgG (H+L)-HRP-conjugated secondary antibodies were from Bio-Rad Laboratories (Hercules, CA, USA). Anti-cleaved-Tau (TauC3) was a kind gift of Prof. Binder Lester I. (Dept. of Cell and Molecular Biology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA). Roscovitine, okadaic acid, zVADfmk, Calpain inhibitor II and JNK inhibitor I were from Calbiochem (Merck KGaA, Darmstadt, Germany). Alexa Fluor® 488-Phalloidin was from Invitrogen (Carlsbad, CA, USA). OxyBlot™ detection kit was from Chemicon (Temecula, CA, USA). All other chemicals were obtained from Merck (Darmstadt, Germany).

Cell cultures and treatments
----------------------------

SH-SY5Y and HeLa cells were purchased from the European Collection of Cell Cultures. hSOD cells were obtained by stably overexpressing SOD1 in SH-SY5Y cells as described previously \[[@b43]\]. SH-SY5Y and HeLa cells were grown in D-MEM-F12 and D-MEM, respectively, supplemented with 10% FCS, 1% penicillin/streptomycin and 1% glutamine (Lonza Ltd, Basel, Switzerland) and hSOD cells maintained in selection with 200 mg/ml G148. Cells were cultured at 37°C in an atmosphere of 5% CO~2~ in air.

Fifty mM solution of DADS was prepared just before the experiments dissolving 5.5 M DADS in dimethyl sulfoxide (DMSO). DADS was used at concentration of 50 μM up to 6 hrs unless otherwise stated. This concentration was selected as we previously demonstrated it was able to give valuable degree of cell cycle arrest and apoptosis at 12 hrs and 24 hrs, respectively, in SH-SY5Y cells \[[@b5], [@b6]\]. The cell permeable calpain inhibitor II (10 μM), caspase-3 inhibitor zVADfmk (20 μM), cdk5 inhibitor roscovitine (1 μM), JNK inhibitor I (10 μM), phosphatases inhibitor okadaic acid (5 or 50 nM) were dissolved in DMSO. NAC and GSH ester were dissolved in phosphate-buffered saline and used at concentration of 5 mM. Overall, these treatments were carried out 1 hr before the addition of DADS and maintained throughout the experiment. As controls, equal amounts of DMSO were added to untreated cells.

For differentiation, SH-SY5Y cells were treated for 5 days with 30 μM retinoic acid, time that resulted in G1/G0 cell cycle arrest, acquisition of the morphology and up-regulation of proteins (such as GAP43) typical of differentiated cells.

Microscopy analysis
-------------------

Cells were seeded directly on glass cover slips 24 hrs before DADS treatment. Cells were fixed with 4% paraformaldehyde and incubated with α-tubulin primary antibody (1:200). Successively, cells were incubated with the appropriate Alexa Fluor®568-conjugated secondary antibody (1:1000). F-actin was stained with Alexa Fluor® Phalloidin-488 (200 nM) and nuclei with Hoechst 33342 (10 μg/ml). Then cover slips were fixed on microscope slides and digitized with a cool snap video camera connected to Nikon Eclipse TE200 epifluorescence microscopy (Nikon, Firenze, Italy). Alternatively, images were acquired on Olympus IX 70 equipped with Nanomover® and softWoRx DeltaVision (Applied Precision Inc., Issaquah, WA, USA) with a U-PLAN-APO 60χ objective. Cell morphology was observed by light microscopy. All images were captured under constant exposure time, gain and offset.

SOD1 enzyme assay
-----------------

SOD1 activity was measured on cell lysates by a polarographic method as reported previously \[[@b44]\]. Data were expressed as μg/mg protein with reference to purified human Cu,Zn SOD.

Cell fractionation and Western blotting
---------------------------------------

Total cell lysates were obtained resuspending cell pellets in lysis buffer containing 10 mM Tris-HCl, pH 7.4, 5 mM EDTA, 150 mM NaCl, 0.5% IGEPAL CA-630, proteases and phosphatases inhibitors cocktail. The Triton-soluble cytosolic components were separated from the Triton-insoluble cytoskeletal components as previously described \[[@b45]\]. Protein content was determined according to Lowry *et al*. \[[@b46]\]. Protein extracts were resuspended in Laemmli Buffer and then electrophoresed on 10% or 12% SDS-polyacrylamide gels and blotted onto nitrocellulose. Membranes were stained with primary antibodies against actin (1:5000), α-tubulin (1:5000), β-tubulin (1:5000), p-cdk5 (1:2000), p-Bcl-2 (1:1000) or Tau (1:2000). Detection of cleaved Tau was carried out using a TauC3 monoclonal antibody according to Gamblin *et al*. \[[@b47]\], and 6-hr treatment with 0.5 μM staurosporine was used for Tau cleavage positive control \[[@b39]\]. After incubation with the appropriate HRP-conjugated secondary antibodies (1:10000), protein bands were detected using a Fluorchem Imaging system upon incubation with ChemiGlow chemiluminescence substrate (Alpha Innotech, San Leandro, CA, USA). Density of immunoreactive bands was calculated using the software AlphaEaseFC and normalized for α-tubulin or Ponceau Red staining. For Ponceau Red normalization, we considered the density of the each entire lane obtained after staining of blotted nitrocellulose membrane.

Determination of protein carbonylation
--------------------------------------

For determination of protein carbonyls, cytoskeletal and cytosolic proteins were extracted according to Morris *et al*. \[[@b48]\]. Carbonylated proteins were detected using the OxyBlot™ Kit (Chemicon) according to the manufacturer's instruction. Briefly, 5 μg of cytoskeletal proteins were reacted with 2,4-dinitrophenylhydrazine (DNP) for 15 min. at 25°C. Samples were resolved on 10% SDS-polyacrylamide gels and DNP-derivatized proteins were identified by Western blot analysis using an anti-DNP antibody and an appropriate HRP-conjugated secondary antibody.

Analysis of cell cycle and apoptosis
------------------------------------

Cells were stained with 50 μg/ml propidium iodide (dissolved in sodium citrate 1 mg/ml, 0.1% Triton X-100) prior cytofluorimetric analysis with FACScalibur instrument (Beckton & Dickinson, San José, CA, USA). The percentages of cells in G2/M phase and apoptotic cells were evaluated according to Nicoletti *et al*. \[[@b49]\] by using the WinMDI 2.8 software (the Scripps Research Institute, La Jolla, CA, USA).

Statistical analysis
--------------------

The results are presented as means ± S.D. Statistical evaluation was conducted by ANOVA, followed by the *post hoc* Student--Newman--Keuls. Differences were considered to be significant at *P* \< 0.05.

Results
=======

DADS induces cytoskeletal alterations in SH-SY5Y cells
------------------------------------------------------

Previously we demonstrated that DADS induces oxidative stress, cell cycle arrest and apoptosis in tumour cells of neuronal origin *via* a ROS-mediated activation of JNK/c-Jun signalling pathway \[[@b5], [@b6]\]. In this report, we have focused on early effects of DADS treatment in order to characterize the molecular events upstream of induction of apoptosis in SH-SY5Y cells. We analysed cell morphology at early stages (during the first 6 hrs) after 50 μM DADS administration, a concentration that efficiently triggers apoptosis at 24 hrs \[[@b6], [@b7]\]. As reported in [Fig. 1A](#fig01){ref-type="fig"}, control cells displayed the shape typical of SH-SY5Y neuroblastoma cells, whereas morphology of DADS-treated cells was altered starting from 1 hr with the number and extension of neurites significantly reduced. These variations preceded the blockage of cell cycle and induction of death, which was significant only after 12 hrs of DADS treatment \[[@b5]\].

![DADS treatment induces alteration of cell morphology and microfilaments disruption in SH-SY5Y cells. (A) After 1-hr treatment with 50 μM DADS, SH-SY5Y cells were fixed with paraformaldehyde and morphology was observed by light microscopy. (B) After 1-hr treatment with 50 μM DADS, SH-SY5Y paraformaldehyde-fixed cells were incubated with AlexaFluor468-conjugated Phalloidin to stain F-actin and analysed by fluorescent microscope. Images reported are from one experiment representative of three that gave similar results. (C) SH-SY5Y cells were treated with 50 μM DADS up to 6 hrs. At each time-point, cell pellets were used for separation of cytoskeletal and soluble or total proteins. Proteins were subjected to SDS-PAGE followed by Western blot analysis using an anti-actin antibody. Immunoblots reported are representative of four that gave similar results. Density of immunoreactive bands was measured by Quantity one software (Bio-Rad Laboratories). Data are expressed as means of actin/Ponceau Red ± S.D.; *n*= 4, \**P* \< 0.001.](jcmm0014-0564-f1){#fig01}

To verify whether changes of cell morphology were associated with cytoskeleton alteration, we analysed microfilaments architecture after staining of actin stress fibres (F-actin) with Alexa Fluor 488-conjugated phalloidin. As reported in the panels of [Fig. 1B](#fig01){ref-type="fig"}, phalloidin staining confirmed the morphological changes observed in cells treated with DADS with respect to controls. Moreover, this analysis revealed that F-actin was considerably reduced starting at 1 hr ([Fig. 1B](#fig01){ref-type="fig"}). Western blot analysis carried out on cytoskeletal protein extracts evidenced that cytoskeletal actin was significantly reduced up to 6 hrs with a concomitant accumulation of its content in soluble fraction ([Fig. 1C](#fig01){ref-type="fig"}). Moreover, total actin protein content was not altered confirming that a depolymerization process of microfilaments was occurring.

To deeply dissect the effects of DADS on cytoskeleton, we analysed both microtubules and microfilaments by an Olympus IX 70 equipped with Nanomover® and softWoRx DeltaVision fluorescent microscopy. Immunostaining of α-tubulin demonstrated that cells treated with DADS displayed a dramatic alteration of microtubules network contemporarily to F-actin loss ([Fig. 2](#fig02){ref-type="fig"}). In fact, while control cells displayed a well-defined microtubular organization, DADS-treated cells had a punctuated and disordered tubulin lattice. Nuclei staining with Hoechst 33342 also confirmed that cytoskeleton impairment occurred very early with respect to cell cycle blockage, as G2/M arrested cells were not still detected (data not shown). Figure 3A shows that DADS caused a significant decrease of β-tubulin in the cytoskeletal fraction starting at 3 hrs and a concomitant increase of the protein in the cytosolic counterpart, which reached the maximum level at 6 hrs, indicating a depolymerization process of microtubules. As seen for actin, total α-tubulin content was not altered ([Fig. 3B](#fig03){ref-type="fig"}). However, the occurrence of microtubules disruption was further confirmed by analysing the content of Bcl-2 protein phophorylated on Ser70, which is widely considered a marker of microtubules depolymerization. Indeed, anti-microtubule agents (*e.g.* taxol, vincristine, vinblastine, nocodazole) can trigger Bcl-2 phosphorylation at G2/M phase of the cell cycle in a variety of human tumour cell lines \[[@b50], [@b51]\]. Western blot analysis, using an anti-phospho-Bcl-2 (p-Bcl-2) antibody specifically recognizing the phosphorylated Ser70, revealed that p-Bcl-2 increased time-dependently ([Fig. 3B](#fig03){ref-type="fig"}).

![DADS treatment alters microtubules network in SH-SY5Y cells. After 3-hr treatment with 50 μM DADS, SH-SY5Y cells were fixed with paraformaldehyde and were incubated with AlexaFluor488-conjugated Phalloidin to stain F-actin (green), with an anti-α-tubulin and with the appropriate AlexaFluor568-conjugated secondary antibody to stain microtubules (red). Images reported are from one experiment representative of four that gave similar results.](jcmm0014-0564-f2){#fig02}

![DADS treatment induces microtubules depolymerization in SH-SY5Y cells. (A) SH-SY5Y cells were treated with 50 μM DADS up to 6 hrs. At each time-point, cell pellets were used for separation of cytoskeletal and soluble proteins. Proteins were subjected to SDS-PAGE followed by Western blot analysis using an anti-β-tubulin antibody. Immunoblots reported are representative of four that gave similar results. Density of immunoreactive bands was measured by Quantity one software (Bio-Rad Laboratories). Ponceau Red protein staining on nitrocellulose membrane was used as loading control. Data are expressed as means of β-tubulin/Ponceau Red ± S.D.; *n*= 4, \**P* \< 0.01, \*\**P* \< 0.001. (B) SH-SY5Y cells were treated with 50 μM DADS up to 6 hrs. At each time-point, cell pellets were used for total proteins extraction. Proteins were subjected to SDS-PAGE followed by Western blot analysis using an anti-p-Bcl-2 antibody. Anti-α-tubulin was used as loading control. Immunoblots reported are from one experiment representative of four that gave similar results. Density of immunoreactive bands was measured by Quantity one software (Bio-Rad Laboratories). Data are expressed as means of p-Bcl-2/α-tubulin ± S.D.; *n*= 3, \**P* \< 0.001.](jcmm0014-0564-f3){#fig03}

Superoxide is implicated in microfilaments and microtubules disruption
----------------------------------------------------------------------

DADS is a pro-oxidant molecule able to rapidly increase intracellular ROS content and irreversibly damage cellular components including membrane lipids, nucleus and proteins \[[@b5]--[@b7], [@b29]\]. We previously demonstrated that SH-SY5Y cells stably overexpressing SOD1 (hSOD cells) displayed increased superoxide dismutase activity with respect to SH-SY5Y cells (2.80 ± 0.12 μg/mg prot *versus* 0.95 ± 0.08) and efficiently counteracted both the ROS burst and the pro-apoptotic action of DADS \[[@b5]\]. In fact, as reported in [Fig. 4A](#fig04){ref-type="fig"}, a significant reduction of apoptotic cells was obtained at 24 hrs. Since cytoskeleton is considered one of the main targets of ROS, we asked whether hSOD cells could escape microfilaments- and/or microtubules-disrupting action of DADS.

![SOD1 overexpression protects SH-SY5Y from cytoskeletal disruption. (A) SH-SY5Y and hSOD cells were treated with 50 μM DADS for the indicated times. Cytofluorimetric analysis of apoptosis was carried out after staining of nuclei with propidium iodide. Data are expressed as means ± S.D.; *n*= 8, \**P* \< 0.001. (B) hSOD cells were treated with 50 μM DADS up to 6 hrs. At each time-point, cell pellets were used for separation of cytoskeletal and soluble proteins. Proteins were subjected to SDS-PAGE followed by Western blot analysis using an anti-β-tubulin or anti-actin antibody. Immunoblots reported are from one experiment representative of four that gave similar results. (C) SH-SY5Y and hSOD cells were treated with 50 μM DADS up to 12 hrs. At each time-point, cell pellets were used for separation of cytoskeletal or soluble proteins. Protein carbonyls were derivatized with DNP and subjected to SDS-PAGE followed by Western blot analysis using an anti-DNP antibody. Immunoblot reported is representative of four that gave similar results. Density of immunoreactive bands was measured by Quantity one software (Bio-Rad Laboratories). Ponceau Red protein staining on nitrocellulose membrane was used as loading control. Data are expressed as means of protein carbonyls/Ponceau Red ± S.D.; *n*= 4, \**P* \< 0.01, \*\**P* \< 0.001.](jcmm0014-0564-f4){#fig04}

Western blot analysis of actin and β-tubulin on soluble and cytoskeletal fractions evidenced that the content of these proteins was not altered in hSOD cells treated with DADS ([Fig. 4B](#fig04){ref-type="fig"}).

These results suggested that cytoskeleton disassembly could depend on superoxide-mediated oxidative modifications of its protein constituents. To verify this hypothesis, we measured the level of carbonyl residues in cytoskeletal protein extracts. After derivatization of carbonyls with DNP, cytoskeletal protein extracts from either SH-SY5Y or hSOD cells were subjected to Western blot analysis using an anti-DNP antibody. As reported in [Fig. 4C](#fig04){ref-type="fig"}, cytoskeletal proteins of SH-SY5Y cells were oxidatively damaged as early as after 1 hr reaching a peak level at 12 hrs. On the contrary, cytoskeletal proteins of hSOD cells were faintly carbonylated only at 3 and 6 hrs to finally return to the basal level at 12 hrs after DADS administration.

DADS induces PP1-mediated Tau dephosphorylation
-----------------------------------------------

On the basis of the results obtained on cytoskeletal disassembly, we asked whether Tau could be affected in the early hours after DADS administration. To this end, we analysed Tau protein by Western blot analysis using an antibody directed against all Tau isoforms and recognizing it independently on its phosporylation state. As showed in [Fig. 5A](#fig05){ref-type="fig"}, the monoclonal antibody recognized a major Tau band and a faint band at higher molecular weight. DADS treatment caused an early shift of the bands towards lower molecular weights, which remained constant for all the time-points screened. The appearance of low molecular weight forms of Tau has been frequently ascribed to many factors including dephosphorylation, calpains- or caspases-mediated cleavage \[[@b39], [@b52]\]. We therefore investigated the possible involvement of calpains and caspases in Tau processing by treating SH-SY5Y cells with chemical inhibitors of these two proteases, specifically 20 μM z-VAD~FMK~ and 10 μM calpain inhibitor II. As evidenced in the immunoblot reported in [Fig. 5B](#fig05){ref-type="fig"}, none of the two inhibitors used were able to reconstitute the control Tau pattern. To confirm this result, cell lysates were also used for Western blot analysis using an antibody specific for the caspases-cleaved form of Tau. As positive control, we treated cells with the pro-apoptotic agent staurosporine, which efficiently induces Tau processing by caspase-3 during neuronal apoptosis \[[@b39]\]. As showed in immunoblot reported in [Fig. 5C](#fig05){ref-type="fig"}, this analysis revealed that Tau was not cleaved during DADS treatment, whereas a strong Tau-cleaved immunoreactive band was observed in cells treated with staurosporine. We then attempted to explore whether Tau could be dephosphorylated by the action of protein phospatase-1 and/or -2A (PP1 and PP2A), which have been identified as the principal phosphatases modulating Tau phosphorylation state also in SH-SY5Y cells \[[@b53], [@b54]\]. We therefore co-treated cells with okadaic acid (OA), a strong inhibitor of both PP1 and PP2A in dependence of its concentration. Western blot analysis of Tau showed that PP2A was not involved in Tau dephosphorylation as no significant changes were detected in cells treated with DADS or in combination with 5 nM OA ([Fig. 5D](#fig05){ref-type="fig"}), concentration exclusively inhibiting PP2A. Instead, concomitant inhibition of PP1 and PP2A by treatment with 50 nM OA completely abolished the appearance of the lower molecular weight bands observed with DADS treatment alone ([Fig. 5D](#fig05){ref-type="fig"}), suggesting that they likely corresponded to dephosphorylated Tau forms and that a DADS-mediated activation of PP1 occurred. To confirm this hypothesis, we carried out Western blot analysis also with Tau-1 antibody, which specifically recognizes only the dephosphorylated forms of Tau. Figure 5E shows that after DADS treatment Tau dephosphorylated bands increased in number and immunoreactivity.

![DADS induces PP1-mediated Tau dephosphorylation. (A) SH-SY5Y cells were treated with 50 μM DADS up to 6 hrs. At each time-point, cell pellets were lysed and total protein extracts were subjected to SDS-PAGE followed by Western blot analysis using an anti-Tau antibody recognizing Tau protein independently of its phosphorylation state and anti-α-tubulin antibody as loading control. Immunoblots reported are from one experiment representative of four that gave similar results. (B) One hour before 50 μM DADS treatment, caspase 3 inhibitor (zVADfmk) or calpain inhibitor II was added to culture medium and maintained throughout the experiment. After 3 hrs, cell pellets were lysed and total protein extracts were subjected to SDS-PAGE followed by Western blot analysis using an anti-Tau antibody recognizing Tau protein independently on its phosphorylation state and anti-α-tubulin antibody as loading control. Immunoblots reported are from one experiment representative of four that gave similar results. (C) SH-SY5Y cells were treated with 50 μM DADS for 6 hrs. Cell pellets were lysed and total protein extracts were subjected to SDS-PAGE followed by Western blot analysis using an anti-TauC3 antibody recognizing only its caspase 3-cleaved form and anti-α-tubulin antibody as loading control. Six-hour treatment with 0.5 μM staurosporine was used as positive control. Immunoblots reported are from one experiment representative of three that gave similar results. (D) One hour before 50 μM DADS treatment, okadaic acid (OA) was added to culture medium and maintained throughout the experiment. After 3 hrs, cell pellets were lysed and total protein extracts were subjected to SDS-PAGE followed by Western blot analysis using an anti-Tau antibody recognizing Tau protein independently on its phosphorylation state and anti-α-tubulin antibody as loading control. Immunoblots reported are from one experiment representative of three that gave similar results. (E) SH-SY5Y cells were treated with 50 μM DADS up to 6 hrs. At each time-point, cell pellets were lysed and total protein extracts were subjected to SDS-PAGE followed by Western blot analysis using an anti-Tau1 antibody recognizing only Tau dephosphorylated forms and anti-α-tubulin antibody as loading control. Immunoblots reported are from one experiment representative of three that gave similar results.](jcmm0014-0564-f5){#fig05}

DADS-mediated ROS increase is responsible for Tau dephosphorylation
-------------------------------------------------------------------

It has been established that PP1 is activated by oxidative stress leading to dephosphorylation of its substrates including Tau \[[@b55]--[@b57]\]. Indeed, PP1 can be activated directly by H~2~O~2~\[[@b58]\] or by the redox-mediated dissociation of its inhibitory partners \[[@b59]\]. The latter is a regulatory mechanism that mainly involves the binding of the inhibitor protein 2 (I-2), which can be reversed under oxidative stimuli by cdk5-mediated phosphorylation of I-2 \[[@b57], [@b60]\]. To assess whether cdk5 could be involved in the signalling pathway converging to Tau dephosphorylation, we carried out Western blot analysis of phosho-active cdk5 (p-cdk5). Figure 6A shows that DADS treatment was not associated with the induction of cdk5 phosphorylation, indicating that this kinase was not involved. Moreover, experiments carried out in the presence of the cdk5 inhibitor roscovitine demonstrated that Tau dephosphorylation was not prevented ([Fig. 6B](#fig06){ref-type="fig"}), thus excluding the influence of cdk5 on Tau phosphorylation in our experimental model. We then investigated whether JNK, which is strongly activated following DADS treatment \[[@b5]\], could be the up-stream mediator of tau dephosphorylation. Experiments carried out in the presence of the synthetic inhibitor of JNK (JNK inhibitor I) demonstrated that it did not prevent tau dephosphorylation ([Fig. 6B](#fig06){ref-type="fig"}). On the basis of these results, we attempted to analyse the possible direct participation of ROS on the route leading to Tau dephosphorylation. To test this hypothesis, we examined Tau in hSOD cells: contrarily to microtubules and microfilaments, SOD1 overexpression had no inhibitory effects on Tau dephosphorylation ([Fig. 6C](#fig06){ref-type="fig"}), implying that superoxide could not mediate this event. To assess whether H~2~O~2~ could be involved, we pre-treated cells with two-electron reductants such as NAC or GSH-ester prior to DADS administration and we subsequently analysed Tau by Western blot. As showed in immunoblot reported in [Fig. 6D](#fig06){ref-type="fig"}, both antioxidants were able to efficiently prevent Tau dephosphorylation. Concomitantly, NAC pre-treatment completely abolished DADS disrupting action both on microtubules and microfilaments ([Fig. 7A](#fig07){ref-type="fig"}). As reported in [Fig. 7B](#fig07){ref-type="fig"}, cytofluorimetric analysis upon propidum iodide staining revealed that NAC was also able to completely prevent both G2/M growth arrest and apoptosis.

![Tau dephosphorylation is mediated by H~2~O~2~ and is prevented by NAC and GSH~est~. (A) SH-SY5Y cells were treated with 50 μM DADS. At indicated times, cells were lysed and total protein extracts were subjected to SDS-PAGE followed by Western blot analysis using an anti-p-cdk5 antibody and anti-α-tubulin antibody as loading control. Immunoblots reported are from one experiment representative of three that gave similar results. (B) One hour before 50 μM DADS treatment, 1 μM roscovitin (*Rosc*) or JNK inhibitor I (*JNK inh*) was added to culture medium and maintained throughout the experiment. After 3 hrs, cell pellets were lysed and total protein extracts were subjected to SDS-PAGE followed by Western blot analysis using an anti-Tau antibody recognizing Tau protein independently on its phosphorylation state and anti-α-tubulin antibody as loading control. Immunoblots reported are from one experiment representative of three that gave similar results. (C) Cu,Zn SOD overexpressing cells (hSOD) were treated with 50 μM DADS up to 6 hrs. At each time-point, cell pellets were lysed and total protein extracts were subjected to SDS-PAGE followed by Western blot analysis using an anti-Tau antibody recognizing Tau protein independently on its phosphorylation state and anti-α-tubulin antibody as loading control. Immunoblots reported are from one experiment representative of four that gave similar results. (D) One hour before 50 μM DADS treatment, 5 mM NAC or 5 mM GSH~est~ was added to culture medium and maintained throughout the experiment. After 3 hrs, cell pellets were lysed and total protein extracts were subjected to SDS-PAGE followed by Western blot analysis using an anti-Tau antibody recognizing Tau protein independently on its phosphorylation state and anti-α-tubulin antibody as loading control. Immunoblots reported are from one experiment representative of three that gave similar results.](jcmm0014-0564-f6){#fig06}

![NAC protects from DADS-induced cytoskeleton disruption and apoptosis. (A) One hour before 50 μM DADS treatment, 5 mM NAC was added to culture medium and maintained throughout the experiment. After 3-hr treatment with 50 μM DADS, SY-SY5Y cells were fixed with paraformaldehyde and incubated with AlexaFluor488-conjugated Phalloidin to stain F-actin (green) and with an anti-α-tubulin to stain microtubules (red). After incubation with the appropriate AlexaFluor568-conjugated secondary antibody, cells were observed by fluorescent microscope. Images reported are from one experiment representative of three that gave similar results. (B) One hour before 24-hr treatment with 50 μM DADS, 5 mM NAC was added to culture medium and maintained throughout the experiment. Cytofluorimetric analysis of apoptosis and cell cycle phases were carried out after staining of nuclei with propidium iodide. Data are expressed as means ± S.D.; *n*= 8, \**P* \< 0.001. (C) HeLa cells were treated with 50 μM DADS for 24 hrs. Cytofluorimetric analysis of apoptosis was carried out after staining of nuclei with propidium iodide. Data are expressed as means ± S.D.; *n*= 4, \**P* \< 0.001.](jcmm0014-0564-f7){#fig07}

HeLa cells, which do not have cytoskeletal-associated Tau protein, were treated with the same concentration of DADS. Figure 7C shows that these cells are less susceptible to DADS toxicity indicating that Tau could play a synergistic role in apoptosis commitment.

We previously demonstrated that differentiated SH-SY5Y cells were not committed to apoptosis by DADS treatment \[[@b6]\]. Therefore, we analysed the effects of DADS on cytoskeleton network of SH-SY5Y differentiated with retinoic acid. We found that these cells were still sensitive to anti-cytoskeleton action of DADS as they underwent both microfilaments/microtubules disruption and Tau dephosphorylation (data not shown), indicating that cytoskeletal disrupting action of DADS could be more detrimental for proliferating cells.

Discussion
==========

Anti-cancer drugs interfering with cytoskeletal dynamics are currently employed in chemotherapy and the most successful in inhibiting proliferation without affecting cytoskeleton of normal cells are those targeting microtubules and impeding mitotic spindle assembly \[[@b28]\]. As previously suggested, some organosulphur garlic compounds including DADS exert anti-mitotic effects that nicely resembles those of the most used anti-microtubules agents such as nocodazole and *Vinca* alkaloids \[[@b30]--[@b33], [@b61]\]. The unique proposed mechanism of action is microtubules oxidation by direct binding on tubulin at alternative sites with respect to the above-mentioned drugs. In particular, adducts between the organosulphur compound and tubulin cysteine thiols have been suggested to be formed since sulphydryls-reducing agents (dithiotreitol and β-mercaptoethanol) abolish the disrupting effect on microtubules. The subsequent identification of an allylmercaptocysteine adducts on Cys^12^ and Cys^354^ of β-tubulin gave the ultimate demonstration of the fundamental role of allyl mojety in causing mitotic arrest through microtubules oxidation and destabilization \[[@b32]\]. Our results are in line with the notion that DADS causes impairment of microtubules as we detected a significant loss of microtubules network together with a rapid and abnormal accumulation of soluble β-tubulin with the cytoskeletal counterpart being concomitantly reduced. Disassembly activity of DADS on microtubules was also confirmed by analysing phopshorylation of Bcl-2 on Ser70, which is generally considered a marker of microtubules impairment \[[@b50], [@b51]\]. p-Bcl-2 increased irrespective of total decrement of non-phosphorylated Bcl-2, which we previously detected at early times after DADS administration, indicating a strong anti-microtubules activity of DADS. By the use of SOD1 overexpressing cells we demonstrated that microtubules disassembly could be triggered only in the presence of superoxide. Indeed, SH-SY5Y cells underwent oxidative modifications of cytoskeletal proteins and hSOD cells were highly protected both from carbonylation and from microtubules depolymerization. These data nicely correlate with those previously obtained in our laboratory, which showed carbonylation in total protein extracts of SH-SY5Y cells \[[@b5]\], indicating that carbonylation of cytoskeletal proteins has a significant contribute in the raise of total protein carbonyls. Our results do not exclude that the allylation of β-tubulin also occurs but rather they imply that DADS-derived superoxide, besides causing oxidative damage through carbonylation, was somehow necessary to allow the reaction of allyl moiety with β-tubulin thiols.

While the occurrence of microtubules depolymerization upon treatment with allyl-containing garlic derivatives was already suggested by other authors, the present work gives the first evidence of microfilaments disruption. Like microtubules, microfilaments can undergo oxidative modifications both on methionine and cysteine of actin upon treatment with oxidizing agents \[[@b8], [@b9], [@b62]\]. It was therefore plausible that the oxidative action of DADS could affect also microfilament network. However, to the best of our knowledge, only the effects of allicin on microfilaments have been explored with conflicting results. In fact, Prager-Khoutorsky and co-workers reported that allicin treatment did not cause alteration of F-actin in fibroblast, while the group of Sela stated that allicin interfered with the reorganization of cortical actin impairing T cells motility \[[@b33], [@b35]\]. The appearance of carbonylated proteins in cytoskeletal fraction with broad molecular weight range strongly supported that a general oxidation process occurred inside cytoskeleton of DADS-treated cells, which was not limited to tubulin. Actually, the results on microfilaments were comparable to those obtained on microtubules as demonstrated by the overlapping kinetics of actin and tubulin decrement in cytoskeletal fraction and their accumulation in the non-polymerized counterpart. Similarly, upon SOD1 overexpression, DADS failed in inducing microfilaments alteration. Thus, we suggest that DADS-derived superoxide actively participates in both actin and tubulin oxidation ultimately contributing to microfilaments and microtubules disruption.

Another unexplored event that we evidenced was the capacity of DADS to affect Tau state. This microtubules-associated protein is largely expressed in neurons and is involved in assembly and stabilization of microtubules \[[@b36], [@b63]\]. Tau function is regulated by a serine/threonine phosphorylation mechanism involving the concerted activity of specific kinases and phosphatases \[[@b59], [@b64]\]. Abnormal accumulation of hyperphosphorylated and dephosphorylated forms of Tau are associated with several tauopathies and neuronal apoptosis, respectively \[[@b25], [@b38], [@b39], [@b64]\]. It has been demonstrated that microtubules disassembly is necessary for Tau dephosphorylation to occur and this event precedes the apoptosis execution phase \[[@b65]\]. The results obtained from hSOD cells indicate that Tau dephosphorylation and microfilaments/microtubules disruption could be unlinked phenomena. During apoptosis, Tau can undergo caspases- or calpains-mediated cleavage \[[@b38], [@b47]\]. In our experimental model, the alteration of Tau pattern was not due to its cleavage either by caspase-3 or by calpains inhibitors. In addition, the time in which Tau state is altered did not coincide with that of caspase-3 activation, which became significant only later \[[@b5]\]. Our results strongly indicate that Tau was dephosphorylated, as demonstrated by the use of Tau-1 antibody specifically recognizing only its dephosphorylated forms. Moreover, this event occurs by a mechanism involving PP1 activation. Indeed, when we pre-incubated the cells with OA, at concentration inhibiting PP1, Tau phosphorylation pattern was not affected by DADS.

PP1 is a serine/threonine phosphatase having several protein substrates including phosphorylated Tau \[[@b64]\]. PP1 is regulated by multiple mechanisms among which the interaction with inhibitor subunits is the most characterized \[[@b59]\]. The concept that PP1 activity can be modulated in a redox-dependent manner is gradually emerging. It has been recently demonstrated that, upon oxidative insult, PP1 activity is stimulated after detachment of the inhibitor I-2 through the cdk5 redox-dependent pathway. Likewise, oxidative burst allows activating PP1 to dephosphorylate Tau \[[@b57]\]. Although ROS production was early enhanced upon DADS treatment in SH-SY5Y cells \[[@b5]\], an increase of cdk5 phopho-active form was not found and the selective cdk5 inhibitor roscovitine did not impede alteration of Tau state, excluding the involvement of p35/cdk5 pathway in this process. The experiments carried out with the JNK inhibitor demonstrated that this kinase did not participate in the route leading to Tau dephosphorylation. Conversely, our results sustain the idea that Tau dephosphorylation could be triggered by the direct action of ROS on PP1. Particularly, H~2~O~2~ seems to be the species mainly causing Tau dephosphorylation. Actually, we found that in SH-SY5Y cells Tau can be dephosphorylated by H~2~O~2~ treatment but not by the superoxide-generating agents paraquat and rotenone (data not shown). Here we show that overexpression of SOD1 did not prevent DADS-mediated Tau dephosphorylation, indicating that superoxide is not involved in this process. Our hypothesis is supported by the data reported by Sommer *et al*., who demonstrated that purified PP1 is significantly activated by H~2~O~2~ but not by superoxide \[[@b58]\]. The idea that Tau alteration is an H~2~O~2~-mediated process is also confirmed by results obtained in the presence of the more general ROS scavengers NAC and GSH-ester, which completely abolished Tau dephosphorylation. NAC was also the most efficient agent able to completely impede early microfilaments/microtubules disassembly and counteract G2/M arrest and apoptosis. This confirms that cytoskeletal filaments integrity can be preserved not only by scavenging superoxide through SOD1, but also by maintaining the reduced cytoskeletal proteins thiols as suggested for NAC by Hosono and co-workers \[[@b34]\]. The full capacity of NAC to preserve DADS-treated cells could therefore be the results of its double action on microfilaments/microtubules and Tau. The results obtained suggest that G2/M arrest and apoptosis can be mostly prevented through blockage of cytoskeletal filaments depolymerization (*e.g.* by SOD1 overexpression or by NAC treatment) and that Tau more marginally participate in apoptosis commitment. In fact, hSOD cells display a non-complete protection against DADS-induced apoptosis that can be accounted for the occurrence of Tau dephosphorylation. Moreover, we found that inhibition of PP1 significantly decrease apoptotic cell death (data not shown) implying that Tau dephosphorylation and PP1 could contribute to DADS-mediated cytotoxicity.

Moreover, we show that HeLa cells, which do not express cytoskeletal Tau, are more resistant to DADS-mediated apoptosis, reinforcing the hypothesis for a synergistic role of Tau in the induction of cell death in tumour cells of neuronal origin.

A plausible schematic model of the anti-cytoskeleton action of DADS is presented in [Fig. 8](#fig08){ref-type="fig"}.

![Schematic model of the anti-cytoskeleton action of DADS. Tau dephosphorylation is likely caused by H~2~O~2~-mediated activation of PP1. Both OA and NAC treatments prevent Tau dephosphorylation by inhibiting PP1 and scavenging H~2~O~2~, respectively. Microfilaments and microtubules architecture is impaired by superoxide and allyl moiety and is preserved both by SOD1 and NAC. Tau dephosphorylation and microfilaments/microtubules depolymerization are two independent phenomena that differently contribute to G2/M arrest and apoptosis commitment. The latter event appears to give the more relevant contribution to the anti-proliferative effects of DADS. DADS: diallyl disulphide; PP1: protein phosphatase 1; OA: okadaic acid; SOD1: copper,zinc superoxide dismutase; NAC: N-acetyl-L-cysteine.](jcmm0014-0564-f8){#fig08}

As both microtubules and actin filaments play important roles in mitosis, cell signalling and motility of proliferating cells, these cytoskeletal filaments are the targets of a growing number of anti-cancer drugs. However, only anti-microtubules agents have been successfully employed in cancer management as microfilaments poisons display high cytotoxicity for non-cancerous cells as well. Even if less significant with respect to undifferentiated cells, also retinoic acid-treated SH-SY5Y cells underwent cytoskeleton depolymerization and Tau dephosphorylation (data not shown). However, regardless of the cytoskeleton alteration, they were completely resistant to DADS-mediated apoptosis \[[@b6]\], demonstrating that cytoskeleton impairment is lethal only for proliferating cells. Our results give emphasis to the possible employment of DADS in cancer treatment both by virtue of its widespread cytoskeletal alteration and specific cytotoxic action on proliferating neuroblastoma cells. Since neuronal cytoskeleton function highly depends on the phosphorylative status of Tau, the present work highlights Tau as a novel target of DADS anti-cytoskeleton action that can be also exploited for developing new strategy for treatment of neuronal pathologies associated with Tau hyperphosphorylation and phosphatases activity impairment (*i.e.* tauopathies).

We gratefully acknowledge Palma Mattioli for her assistance in microscopy and image analysis. This work was partially supported by grants from Ministero della Salute and MIUR, FIRB 'Idee Progettuali'.
